TD Cowen lowered the firm’s price target on P3 Health Partners (PIII) to 25c from 90c and keeps a Hold rating on the shares. The firm updated its model to reflect 3Q24 results. The model assumes the company requires a $100m capital raise in 2025 to support continued operating losses.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PIII:
Questions or Comments about the article? Write to editor@tipranks.com